Detalhe da pesquisa
1.
Glutamate dehydrogenase 1: A novel metabolic target in inhibiting acute myeloid leukaemia progression.
Br J Haematol
; 202(3): 566-577, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37231991
2.
circSLC25A13 acts as a ceRNA to regulate AML progression via miR-616-3p/ADCY2 axis.
Mol Carcinog
; 62(10): 1546-1562, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37493101
3.
Spermatogenesis associated serine rich 2 like plays a prognostic factor and therapeutic target in acute myeloid leukemia by regulating the JAK2/STAT3/STAT5 axis.
J Transl Med
; 21(1): 115, 2023 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36774517
4.
FLOT1 knockdown inhibits growth of AML cells through triggering apoptosis and pyroptosis.
Ann Hematol
; 102(3): 583-595, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36697954
5.
Homoharringtonine is synergistically lethal with BCL-2 inhibitor APG-2575 in acute myeloid leukemia.
J Transl Med
; 20(1): 299, 2022 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35794605
6.
Inhibition of CPT1a as a prognostic marker can synergistically enhance the antileukemic activity of ABT199.
J Transl Med
; 19(1): 181, 2021 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33926484
7.
m6A-dependent upregulation of DDX21 by super-enhancer-driven IGF2BP2 and IGF2BP3 facilitates progression of acute myeloid leukaemia.
Clin Transl Med
; 14(4): e1628, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38572589
8.
High expression of BCAT1 sensitizes AML cells to PARP inhibitor by suppressing DNA damage response.
J Mol Med (Berl)
; 102(3): 415-433, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38340163
9.
CPT1B, a metabolic molecule, is also an independent risk factor in CN-AML.
Cancer Biomark
; 37(3): 133-145, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36938722
10.
Quercetin improves cerebral ischemia/reperfusion injury by promoting microglia/macrophages M2 polarization via regulating PI3K/Akt/NF-κB signaling pathway.
Biomed Pharmacother
; 168: 115653, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37812891
11.
ACC010, a novel BRD4 inhibitor, synergized with homoharringtonine in acute myeloid leukemia with FLT3-ITD.
Mol Oncol
; 17(7): 1402-1418, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36567628
12.
Dihydropyrimidinase-like 2 can serve as a novel therapeutic target and prognostic biomarker in acute myeloid leukemia.
Cancer Med
; 12(7): 8319-8330, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36621846
13.
Circular RNA LONP2 regulates proliferation, invasion, and apoptosis of bladder cancer cells by sponging microRNA-584-5p.
Bioengineered
; 13(4): 8823-8835, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35358000
14.
Global, regional, and national burdens of leukemia from 1990 to 2017: a systematic analysis of the global burden of disease 2017 study.
Aging (Albany NY)
; 13(7): 10468-10489, 2021 04 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33820874
15.
MAP4K1 functions as a tumor promotor and drug mediator for AML via modulation of DNA damage/repair system and MAPK pathway.
EBioMedicine
; 69: 103441, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34166980
16.
Ibrutinib Suppresses Early Megakaryopoiesis but Enhances Proplatelet Formation.
Thromb Haemost
; 121(2): 192-205, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32961571
17.
Abivertinib synergistically strengthens the anti-leukemia activity of venetoclax in acute myeloid leukemia in a BTK-dependent manner.
Mol Oncol
; 14(10): 2560-2573, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32519423
18.
A novel alkylating deacetylase inhibitor molecule EDO-S101 in combination with cytarabine synergistically enhances apoptosis of acute myeloid leukemia cells.
Med Oncol
; 36(9): 77, 2019 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31372848